Table 3. Risk of PCa as estimated by mtDNA copy number in subgroups of cases and controls with selected characteristics.
Variable | Cases, No.a | Controls, No.a | OR (95%CI)b | P value | ||
High | Low | High | Low | |||
Age, years | ||||||
<70 | 65 | 26 | 45 | 46 | 2.39 (1.28–4.47) | 0.006 |
≥70 | 60 | 42 | 52 | 51 | 1.45 (0.83–2.53) | 0.194 |
BMI, kg/m2 | ||||||
<25 | 76 | 48 | 69 | 69 | 1.54 (0.97–2.64) | 0.063 |
≥25 | 49 | 20 | 28 | 28 | 2.42 (1.14–5.16) | 0.022 |
Smoking status | ||||||
Never | 61 | 32 | 46 | 50 | 1.98 (1.09–3.61) | 0.026 |
Ever | 64 | 36 | 51 | 47 | 1.61 (0.90–2.87) | 0.110 |
Daily dietary fat intakec | ||||||
Low/moderate | 89 | 44 | 77 | 79 | 2.01 (1.24–3.25) | 0.005 |
High | 36 | 24 | 20 | 18 | 1.19 (0.51–2.80) | 0.685 |
Abbreviations: PCa = prostate cancer; mtDNA = mitochondrial DNA; OR = odds ratio; CI = confidence intervals; BMI = body mass index.
Cases and controls were dichotomized based on the median mtDNA copy number in controls.
Analyses were performed using unconditional models adjusted for age, BMI, daily dietary fat intake, smoking status and family history of PCa where appropriate.
The three categories of low, moderate and high are defined in Table 1.